Vera Therapeutics Inc Cl A
(VERA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 167,170 | 102,012 | 90,903 | 34,402 | 52,241 |
| Operating Income | -167,170 | -102,012 | -90,903 | -34,402 | -52,241 |
| Interest Expense | 7,626 | 3,786 | 992 | 20 | 166 |
| Other Income | 22,649 | 9,809 | 2,840 | 1,814 | -1,005 |
| Pre-tax Income | -152,147 | -95,989 | -89,055 | -32,608 | -53,412 |
| Income Tax | -1 | -1 | -1 | -1 | -1 |
| Net Income Continuous | -152,146 | -95,988 | -89,054 | -32,607 | -53,411 |
| Net Income | $-152,146 | $-95,988 | $-89,054 | $-32,607 | $-53,411 |
| EPS Basic Total Ops | -2.75 | -2.25 | -3.35 | -2.43 | -166.93 |
| EPS Basic Continuous Ops | -2.75 | -2.25 | -3.35 | -2.43 | -166.93 |
| EPS Diluted Total Ops | -2.75 | -2.25 | -3.35 | -2.43 | -166.93 |
| EPS Diluted Continuous Ops | -2.75 | -2.25 | -3.35 | -2.43 | -166.93 |
| EPS Diluted Before Non-Recurring Items | -2.75 | -2.25 | -3.35 | -2.43 | N/A |
| EBITDA(a) | $-175,227 | $-106,098 | $-91,749 | $-34,226 | $-51,990 |